↓ Skip to main content

アトピー性皮膚炎におけるヤヌスキナーゼ(JAK)阻害内服薬の使用ガイダンス

Overview of attention for article published in Nihon Hifuka Gakkai zasshi The Japanese journal of dermatology, July 2022
Altmetric Badge

Mentioned by

twitter
1 X user
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
アトピー性皮膚炎におけるヤヌスキナーゼ(JAK)阻害内服薬の使用ガイダンス
Published in
Nihon Hifuka Gakkai zasshi The Japanese journal of dermatology, July 2022
DOI 10.14924/dermatol.132.1797
Authors

日本皮膚科学会アトピー性皮膚炎・蕁麻疹治療安全性検討委員会, 佐伯 秀久, 秋山 真志, 安部 正敏, 五十嵐 敦之, 今福 信一, 大矢 幸弘, 加藤 則人, 亀田 秀人, 椛島 健治, 常深 祐一郎, 秀 道広, 大槻 マミ太郎

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 July 2023.
All research outputs
#17,637,892
of 25,852,155 outputs
Outputs from Nihon Hifuka Gakkai zasshi The Japanese journal of dermatology
#171
of 257 outputs
Outputs of similar age
#258,539
of 437,787 outputs
Outputs of similar age from Nihon Hifuka Gakkai zasshi The Japanese journal of dermatology
#5
of 6 outputs
Altmetric has tracked 25,852,155 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 257 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one is in the 10th percentile – i.e., 10% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 437,787 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 29th percentile – i.e., 29% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one.